⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Atomoxetine
آتوموکستین
🧠 PsychiatrySelective norepinephrine reuptake inhibitor (non-stimulant)
Market / country: 🇺🇸 USA
Strattera (US)
🧮 Dose calculator
Attention-deficit/hyperactivity disorder · Regimen source: FDA Atomoxetine · 2.3 (Highlights dosage table)
- • Target 1.2 mg/kg/day; max 1.4 mg/kg/day or 100 mg, whichever is less. Once in the morning or two equal doses. Do not open capsules. FDA Atomoxetine · 2.3 (Highlights dosage table)FDA Atomoxetine · 2.2
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ MAOI within 14 days; narrow-angle glaucoma; hypersensitivity. FDA Atomoxetine · 4
Warnings
- • Boxed warning: suicidal thoughts and behaviors in pediatric patients ≥6 years; monitor closely. Screen for bipolar history before starting. FDA Atomoxetine · WARNING: SUICIDAL THOUGHTS AND BEHAVIORS IN PEDIATRIC PATIENTSFDA Atomoxetine · 2.1
Formulations
- 10 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
- 18 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
- 25 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
- 40 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
- 60 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
- 80 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
- 100 mg capsule — capsule 🇺🇸 USA FDA Atomoxetine · 3
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Atomoxetine · 3FDA Atomoxetine · 2.3 (Highlights dosage table)FDA Atomoxetine · 2.2FDA Atomoxetine · 4FDA Atomoxetine · WARNING: SUICIDAL THOUGHTS AND BEHAVIORS IN PEDIATRIC PATIENTSFDA Atomoxetine · 2.1
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Clinical review⚠ Unverified